Dr Reddy’s Laboratories announced on Monday that it received a positive inspection report from the US Food and Drug Administration (USFDA) for its manufacturing units in Duvvada, Visakhapatnam. The report classified the facilities as needing “Voluntary Action Indicated” (VAI), meaning that the inspection is considered closed.
Earlier in May, the USFDA had conducted an inspection of these units and issued a Form 483 with two observations. Dr Reddy’s had assured that it would address these issues within the required time.
A Form 483 is given to a company when inspectors observe potential violations of regulations during their review. Dr Reddy’s has since taken steps to correct the issues, leading to the positive conclusion of the inspection.
Disclaimer: The views and investment tips expressed by investment experts on Sharepriceindia.com are their own and not those of the website or its management. Sharepriceindia.com advises users to check with certified experts before taking any investment decisions.
